← Open Payments lookup

SARAH ANSBRO: Open Payments

NPI 1063702637 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,517 in 82 payments from 11 companies in 2025. Trend: 2023 $773 · 2024 $922 · 2025 $1,517

Food & beverage: $1,517
CompanyPaymentsAmount
ABBVIE INC.23$380
Supernus Pharmaceuticals, Inc.11$277
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$227
Otsuka America Pharmaceutical, Inc.13$193
Axsome Therapeutics, Inc.7$155
Teva Pharmaceuticals USA, Inc.4$86
Vanda Pharmaceuticals Inc.4$83
E.R. Squibb & Sons, L.L.C.3$55
Neurocrine BioSciences, Inc.1$25
Takeda Pharmaceuticals U.S.A., Inc.1$20

Products named: VRAYLAR, Qelbree, CAPLYTA, REXULTI, Auvelity, AUSTEDO XR, COBENFY, FANAPT.

Industry payments across TX — which companies pay providers there.